The influence of dietary fat on liver fat accumulation

Nutrients

Volumn 6, Issue 11, 2014, Pages 5018-5033

  Green, Charlotte J ^a   Hodson, Leanne ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Dietary fat; Human; Liver; NAFLD; Steatosis; VLDL TG

Indexed keywords

ACYL COENZYME A DESATURASE; FATTY ACID; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; FAT INTAKE; UNSATURATED FATTY ACID;

AGE; BODY MASS; CALORIC INTAKE; DIET SUPPLEMENTATION; ENDOPLASMIC RETICULUM STRESS; ESTERIFICATION; FAT INTAKE; FATTY ACID METABOLISM; FATTY LIVER; HUMAN; LIPID STORAGE; LIPOGENESIS; OXIDATION; REVIEW; SIGNAL TRANSDUCTION; WAIST CIRCUMFERENCE; ADMINISTRATION AND DOSAGE; COMPLICATION; DIET; FEEDING BEHAVIOR; LIVER; METABOLISM; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY;

ADIPOSITY; DIET; DIETARY FATS; ENERGY INTAKE; FATTY ACIDS, UNSATURATED; FOOD HABITS; HUMANS; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; TRIGLYCERIDES;

EID: 84913591512     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu6115018     Document Type: Review

References (86)

1. Frayn, K.N. Adipose tissue as a buffer for daily lipid flux. Diabetologia 2002, 45, 1201-1210.
2. Yki-Jarvinen, H. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. Dig. Dis. 2010, 28, 203-209.
3. Babin, P.J.; Gibbons, G.F. The evolution of plasma cholesterol: Direct utility or a "spandrel" of hepatic lipid metabolism? Prog. Lipid Res. 2009, 48, 73-91.
4. Diraison, F.; Beylot, M. Role of human liver lipogenesis and reesterification in triglycerides secretion and in ffa reesterification. Am. J. Physiol. 1998, 274, E321-E327.
5. Sidossis, L.S.; Mittendorfer, B.; Walser, E.; Chinkes, D.; Wolfe, R.R. Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion. Am. J. Physiol. 1998, 275, E798-E805.
6. Angulo, P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 2002, 346, 1221-1231.
7. Guan, Y.S.; He, Q. A current update on the rule of alternative and complementary medicine in the treatment of liver diseases. Evid. Based Complement. Altern. Med. 2013, 2013, 321234, doi:10.1155/2013/321234.
8. Chalasani, N.; Younossi, Z.; Lavine, J.E.; Diehl, A.M.; Brunt, E.M.; Cusi, K.; Charlton, M.; Sanyal, A.J. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the AMERICAN Gastroenterological association. Am. J. Gastroenterol. 2012, 107, 811-826.
9. Nascimbeni, F.; Pais, R.; Bellentani, S.; Day, C.P.; Ratziu, V.; Loria, P.; Lonardo, A. From nafld in clinical practice to answers from guidelines. J. Hepatol. 2013, 59, 859-871.
10. Byrne, C.D. Dorothy hodgkin lecture 2012: Non-alcoholic fatty liver disease, insulin resistance and ectopic fat: A new problem in diabetes management. Diabet. Med. 2012, 29, 1098-1107.
11. Vernon, G.; Baranova, A.; Younossi, Z.M. Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment. Pharmacol. Ther. 2011, 34, 274-285.
12. Musso, G.; Gambino, R.; Cassader, M. Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis. Prog. Lipid Res. 2013, 52, 175-191.
13. Yeh, M.M.; Brunt, E.M. Pathological features of fatty liver disease. Gastroenterology 2014, 147, 754-764.
14. Moore, J.B. Non-alcoholic fatty liver disease: The hepatic consequence of obesity and the metabolic syndrome. Proc. Nutr. Soc. 2010, 69, 211-220.
15. Byrne, C.D.; Olufadi, R.; Bruce, K.D.; Cagampang, F.R.; Ahmed, M.H. Metabolic disturbances in non-alcoholic fatty liver disease. Clin. Sci. (Lond.) 2009, 116, 539-564.
16. Lonardo, A.; Sookoian, S.; Chonchol, M.; Loria, P.; Targher, G. Cardiovascular and systemic risk in nonalcoholic fatty liver disease-Atherosclerosis as a major player in the natural course of nafld. Curr. Pharm. Des. 2013, 19, 5177-5192.
17. Fabbrini, E.; Conte, C.; Magkos, F. Methods for assessing intrahepatic fat content and steatosis. Curr. Opin. Clin. Nutr. Metab. Care 2009, 12, 474-481.
18. Fabbrini, E.; Magkos, F.; Mohammed, B.S.; Pietka, T.; Abumrad, N.A.; Patterson, B.W.; Okunade, A.; Klein, S. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc. Natl. Acad. Sci. USA 2009, 106, 15430-15435.
19. Schattenberg, J.M.; Galle, P.R. Animal models of non-alcoholic steatohepatitis: of Mice and man. Dig. Dis. 2010, 28, 247-254.
20. El-Badry, A.M.; Breitenstein, S.; Jochum, W.; Washington, K.; Paradis, V.; Rubbia-Brandt, L.; Puhan, M.A.; Slankamenac, K.; Graf, R.; Clavien, P.A.; et al. Assessment of hepatic steatosis by expert pathologists: The end of a gold standard. Ann. Surg. 2009, 250, 691-697.
21. Kleiner, D.E.; Brunt, E.M.; van Natta, M.; Behling, C.; Contos, M.J.; Cummings, O.W.; Ferrell, L.D.; Liu, Y.C.; Torbenson, M.S.; Unalp-Arida, A.; et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41, 1313-1321.
22. El-Badry, A.M.; Moritz, W.; Contaldo, C.; Tian, Y.; Graf, R.; Clavien, P.A. Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids. Hepatology 2007, 45, 855-863.
23. Reeder, S.B.; Cruite, I.; Hamilton, G.; Sirlin, C.B. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J. Magn. Reson. Imaging 2011, 34, 729-749.
24. Pournik, O.; Alavian, S.M.; Ghalichi, L.; Seifizarei, B.; Mehrnoush, L.; Aslani, A.; Anjarani, S.; Eslami, S. Inter-observer and intra-observer agreement in pathological evaluation of non-alcoholic fatty liver disease suspected liver biopsies. Hepat. Mon. 2014, 14, e15167, doi:10.5812/hepatmon.15167.
25. Vuppalanchi, R.; Unalp, A.; van Natta, M.L.; Cummings, O.W.; Sandrasegaran, K.E.; Hameed, T.; Tonascia, J.; Chalasani, N. Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 2009, 7, 481-486.
26. Havel, R.J.; Kane, J.P.; Balasse, E.O.; Segel, N.; Basso, L.V. Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J. Clin. Investig. 1970, 49, 2017-2035.
27. Hodson, L.; Fielding, B.A. Trafficking and partitioning of fatty acids: The transition from fasted to fed state. Clin. Lipidol. 2010, 5, 131-144.
28. Gibbons, G.F.; Bartlett, S.M.; Sparks, C.E.; Sparks, J.D. Extracellular fatty acids are not utilized directly for the synthesis of very-low-density lipoprotein in primary cultures of rat hepatocytes. Biochem. J. 1992, 287 (Pt. 3), 749-753.
29. Gibbons, G.F.; Wiggins, D. Intracellular triacylglycerol lipase: Its role in the assembly of hepatic very-low-density lipoprotein (vldl). Adv. Enzym. Regul. 1995, 35, 179-198.
30. Gibbons, G.F. Assembly and secretion of hepatic very-low-density lipoprotein. Biochem. J. 1990, 268, 1-13.
31. Zammit, V.A. Role of insulin in hepatic fatty acid partitioning: Emerging concepts. Biochem. J. 1996, 314 (Pt. 1), 1-14.
32. Gibbons, G.F.; Islam, K.; Pease, R.J. Mobilisation of triacylglycerol stores. Biochim. Biophys. Acta 2000, 1483, 37-57.
33. McQuaid, S.E.; Hodson, L.; Neville, M.J.; Dennis, A.L.; Cheeseman, J.; Humphreys, S.M.; Ruge, T.; Gilbert, M.; Fielding, B.A.; Frayn, K.N.; et al. Downregulation of adipose tissue fatty acid trafficking in obesity: A driver for ectopic fat deposition? Diabetes 2011, 60, 47-55.
34. Ruge, T.; Hodson, L.; Cheeseman, J.; Dennis, A.L.; Fielding, B.A.; Humphreys, S.M.; Frayn, K.N.; Karpe, F. Fasted to fed trafficking of fatty acids in human adipose tissue reveals a novel regulatory step for enhanced fat storage. J. Clin. Endocrinol. Metab. 2009, 94, 1781-1788.
35. Pot, G.K.; Prynne, C.J.; Roberts, C.; Olson, A.; Nicholson, S.K.; Whitton, C.; Teucher, B.; Bates, B.; Henderson, H.; Pigott, S.; et al. National diet and nutrition survey: Fat and fatty acid intake from the first year of the rolling programme and comparison with previous surveys. Br. J. Nutr. 2012, 107, 405-415.
36. Bergouignan, A.; Rudwill, F.; Simon, C.; Blanc, S. Physical inactivity as the culprit of metabolic inflexibility: Evidence from bed-rest studies. J. Appl. Physiol. 2011, 111, 1201-1210.
37. Enjoji, M.; Nakamuta, M. Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease? World J. Gastroenterol. 2010, 16, 800-803.
38. Papandreou, D.; Karabouta, Z.; Rousso, I. Are dietary cholesterol intake and serum cholesterol levels related to nonalcoholic fatty liver disease in obese children? Cholesterol 2012, 2012, 572820, doi:10.1155/2012/572820.
39. Ioannou, G.N.; Morrow, O.B.; Connole, M.L.; Lee, S.P. Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the united states population. Hepatology 2009, 50, 175-184.
40. Basaranoglu, M.; Basaranoglu, G.; Sabuncu, T.; Senturk, H. Fructose as a key player in the development of fatty liver disease. World J. Gastroenterol. 2013, 19, 1166-1172.
41. Birkenfeld, A.L.; Shulman, G.I. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology 2014, 59, 713-723.
42. Byrne, C.D. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease. Proc. Nutr. Soc. 2013, 72, 412-419.
43. Hodson, L.; Frayn, K.N. Hepatic fatty acid partitioning. Curr. Opin. Lipidol. 2011, 22, 216-224.
44. Musso, G.; Gambino, R.; Cassader, M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (nafld). Prog. Lipid Res. 2009, 48, 1-26.
45. Scorletti, E.; Byrne, C.D. Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease. Annu. Rev. Nutr. 2013, 33, 231-248.
46. Tappy, L.; Le, K.A. Does fructose consumption contribute to non-alcoholic fatty liver disease? Clin. Res. Hepatol. Gastroenterol. 2012, 36, 554-560.
47. Yasutake, K.; Kohjima, M.; Kotoh, K.; Nakashima, M.; Nakamuta, M.; Enjoji, M. Dietary habits and behaviors associated with nonalcoholic fatty liver disease. World J. Gastroenterol. 2014, 20, 1756-1767.
48. Donnelly, K.L.; Smith, C.I.; Schwarzenberg, S.J.; Jessurun, J.; Boldt, M.D.; Parks, E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Investig. 2005, 115, 1343-1351.
49. Barrows, B.R.; Parks, E.J. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J. Clin. Endocrinol. Metab. 2006, 91, 1446-1452.
50. Hodson, L.; Bickerton, A.S.; McQuaid, S.E.; Roberts, R.; Karpe, F.; Frayn, K.N.; Fielding, B.A. The contribution of splanchnic fat to vldl triglyceride is greater in insulin-resistant than insulin-sensitive men and women: Studies in the postprandial state. Diabetes 2007, 56, 2433-2441.
51. Vedala, A.; Wang, W.; Neese, R.A.; Christiansen, M.P.; Hellerstein, M.K. Delayed secretory pathway contributions to vldl-triglycerides from plasma nefa, diet, and de novo lipogenesis in humans. J. Lipid Res. 2006, 47, 2562-2574.
52. Ravikumar, B.; Carey, P.E.; Snaar, J.E.; Deelchand, D.K.; Cook, D.B.; Neely, R.D.; English, P.T.; Firbank, M.J.; Morris, P.G.; Taylor, R.; et al. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2005, 288, E789-E797.
53. Koch, M.; Borggrefe, J.; Barbaresko, J.; Groth, G.; Jacobs, G.; Siegert, S.; Lieb, W.; Muller, M.J.; Bosy-Westphal, A.; Heller, M.; et al. Dietary patterns associated with magnetic resonance imaging-determined liver fat content in a general population study. Am. J. Clin. Nutr. 2014, 99, 369-377.
54. Kuk, J.L.; Davidson, L.E.; Hudson, R.; Kilpatrick, K.; Bacskai, K.; Ross, R. Association between dietary fat intake, liver fat, and insulin sensitivity in sedentary, abdominally obese, older men. Appl. Physiol. Nutr. Metab. 2008, 33, 239-245.
55. Mollard, R.C.; Senechal, M.; MacIntosh, A.C.; Hay, J.; Wicklow, B.A.; Wittmeier, K.D.; Sellers, E.A.; Dean, H.J.; Ryner, L.; Berard, L.; et al. Dietary determinants of hepatic steatosis and visceral adiposity in overweight and obese youth at risk of type 2 diabetes. Am. J. Clin. Nutr. 2014, 99, 804-812.
56. Sathiaraj, E.; Chutke, M.; Reddy, M.Y.; Pratap, N.; Rao, P.N.; Reddy, D.N.; Raghunath, M. A case-control study on nutritional risk factors in non-alcoholic fatty liver disease in indian population. Eur. J. Clin. Nutr. 2011, 65, 533-537.
57. Bingham, S.A. The dietary assessment of individuals; methods, accuracy, new techniques and recommendations. Nutr. Abstr. Rev. (Ser. A) 1987, 57, 705-742.
58. Biro, G.; Hulshof, K.F.; Ovesen, L.; Amorim Cruz, J.A. Selection of methodology to assess food intake. Eur. J. Clin. Nutr. 2002, 56 (Suppl. 2), S25-S32.
59. Hodson, L.; Skeaff, C.M.; Fielding, B.A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 2008, 47, 348-380.
60. Bjermo, H.; Iggman, D.; Kullberg, J.; Dahlman, I.; Johansson, L.; Persson, L.; Berglund, J.; Pulkki, K.; Basu, S.; Uusitupa, M.; et al. Effects of n-6 pufas compared with sfas on liver fat, lipoproteins, and inflammation in abdominal obesity: A randomized controlled trial. Am. J. Clin. Nutr. 2012, 95, 1003-1012.
61. Bozzetto, L.; Prinster, A.; Annuzzi, G.; Costagliola, L.; Mangione, A.; Vitelli, A.; Mazzarella, R.; Longobardo, M.; Mancini, M.; Vigorito, C.; et al. Liver fat is reduced by an isoenergetic mufa diet in a controlled randomized study in type 2 diabetic patients. Diabetes Care 2012, 35, 1429-1435.
62. Browning, J.D.; Baker, J.A.; Rogers, T.; Davis, J.; Satapati, S.; Burgess, S.C. Short-term weight loss and hepatic triglyceride reduction: Evidence of a metabolic advantage with dietary carbohydrate restriction. Am. J. Clin. Nutr. 2011, 93, 1048-1052.
63. Haufe, S.; Engeli, S.; Kast, P.; Bohnke, J.; Utz, W.; Haas, V.; Hermsdorf, M.; Mahler, A.; Wiesner, S.; Birkenfeld, A.L.; et al. Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatology 2011, 53, 1504-1514.
64. Kirk, E.; Reeds, D.N.; Finck, B.N.; Mayurranjan, S.M.; Patterson, B.W.; Klein, S. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 2009, 136, 1552-1560.
65. Rosqvist, F.; Iggman, D.; Kullberg, J.; Cedernaes, J.; Johansson, H.E.; Larsson, A.; Johansson, L.; Ahlstrom, H.; Arner, P.; Dahlman, I.; et al. Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans. Diabetes 2014, 63, 2356-2368.
66. Sobrecases, H.; Le, K.A.; Bortolotti, M.; Schneiter, P.; Ith, M.; Kreis, R.; Boesch, C.; Tappy, L. Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men. Diabetes Metab. 2010, 36, 244-246.
67. Utzschneider, K.M.; Bayer-Carter, J.L.; Arbuckle, M.D.; Tidwell, J.M.; Richards, T.L.; Craft, S. Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycaemic index diet to reduce liver fat in older subjects. Br. J. Nutr. 2013, 109, 1096-1104.
68. Van der Meer, R.W.; Hammer, S.; Lamb, H.J.; Frolich, M.; Diamant, M.; Rijzewijk, L.J.; de Roos, A.; Romijn, J.A.; Smit, J.W. Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men. J. Clin. Endocrinol. Metab. 2008, 93, 2702-2708.
69. Van Herpen, N.A.; Schrauwen-Hinderling, V.B.; Schaart, G.; Mensink, R.P.; Schrauwen, P. Three weeks on a high-fat diet increases intrahepatic lipid accumulation and decreases metabolic flexibility in healthy overweight men. J. Clin. Endocrinol. Metab. 2011, 96, E691-E695.
70. Westerbacka, J.; Lammi, K.; Hakkinen, A.M.; Rissanen, A.; Salminen, I.; Aro, A.; Yki-Jarvinen, H. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J. Clin. Endocrinol. Metab. 2005, 90, 2804-2809.
71. Bian, H.; Hakkarainen, A.; Lundbom, N.; Yki-Jarvinen, H. Effects of dietary interventions on liver volume in humans. Obesity (Silver Spring) 2014, 22, 989-995.
72. Hodson, L.; McQuaid, S.E.; Karpe, F.; Frayn, K.N.; Fielding, B.A. Differences in partitioning of meal fatty acids into blood lipid fractions: A comparison of linoleate, oleate, and palmitate. Am. J. Physiol. Endocrinol. Metab. 2009, 296, E64-E71.
73. Cussons, A.J.; Watts, G.F.; Mori, T.A.; Stuckey, B.G. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: A randomized controlled trial employing proton magnetic resonance spectroscopy. J. Clin. Endocrinol. Metab. 2009, 94, 3842-3848.
74. Scorletti, E.; Bhatia, L.; McCormick, K.G.; Clough, G.F.; Nash, K.; Hodson, L.; Moyses, H.E.; Calder, P.C.; Byrne, C.D.; On Behalf of the W.S.I. Effects of purified eicosapentaenoic and docosahexaenoic acids in non-alcoholic fatty liver disease: Results from the *WELCOME study. Hepatology 2014, 60, 1211-1221.
75. Vega, G.L.; Chandalia, M.; Szczepaniak, L.S.; Grundy, S.M. Effects of n-3 fatty acids on hepatic triglyceride content in humans. J. Investig. Med. 2008, 56, 780-785.
76. Leamy, A.K.; Egnatchik, R.A.; Young, J.D. Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. Prog. Lipid Res. 2013, 52, 165-174.
77. Tariq, Z.; Green, C.J.; Hodson, L. Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (nash)? Liver Int. 2014, 34, e180-e190.
78. Hodson, L.; Fielding, B.A. Stearoyl-coa desaturase: Rogue or innocent bystander? Prog. Lipid Res. 2013, 52, 15-42.
79. Ricchi, M.; Odoardi, M.R.; Carulli, L.; Anzivino, C.; Ballestri, S.; Pinetti, A.; Fantoni, L.I.; Marra, F.; Bertolotti, M.; Banni, S.; et al. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. J. Gastroenterol. Hepatol. 2009, 24, 830-840.
80. Puri, P.; Baillie, R.A.; Wiest, M.M.; Mirshahi, F.; Choudhury, J.; Cheung, O.; Sargeant, C.; Contos, M.J.; Sanyal, A.J. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007, 46, 1081-1090.
81. Puri, P.; Wiest, M.M.; Cheung, O.; Mirshahi, F.; Sargeant, C.; Min, H.K.; Contos, M.J.; Sterling, R.K.; Fuchs, M.; Zhou, H.; et al. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 2009, 50, 1827-1838.
82. Karpe, F.; Hodson, L. Caution on the interpretation of plasma fatty acid composition as a proxy marker for scd1 activity: Particular implications for using the 16:1/16:0 ratio in qtl studies involving hyperlipidemic patients. Arterioscler. Thromb. Vasc. Biol. 2008, 28, e152, doi:10.1161/ATVB AHA.108.167718.
83. Magkos, F.; Su, X.; Bradley, D.; Fabbrini, E.; Conte, C.; Eagon, J.C.; Varela, J.E.; Brunt, E.M.; Patterson, B.W.; Klein, S.; et al. Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. Gastroenterology 2012, 142, 1444-1446.e2.
84. Koopman, K.E.; Caan, M.W.; Nederveen, A.J.; Pels, A.; Ackermans, M.T.; Fliers, E.; la Fleur, S.E.; Serlie, M.J. Hypercaloric diets with increased meal frequency, but not meal size, increase intrahepatic triglycerides: A randomized controlled trial. Hepatology 2014, 60, 545-553.
85. DeLany, J.P.; Windhauser, M.M.; Champagne, C.M.; Bray, G.A. Differential oxidation of individual dietary fatty acids in humans. Am. J. Clin. Nutr. 2000, 72, 905-911.
86. Moussavi, N.; Gavino, V.; Receveur, O. Could the quality of dietary fat, and not just its quantity, be related to risk of obesity? Obesity (Silver Spring) 2008, 16, 7-15.